Semen Analysis After Proton Therapy for Prostate Cancer

Completed · Not applicable

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to evaluate semen for changes following treatment with proton radiation therapy.

Key facts

Study ID

NCT01072513

Run by

University of Florida

People needed

31

Starts

2010-03-01

Expected to finish

2015-07-01

Last updated by the study team

2016-04-06

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of low to intermediate risk prostate cancer and elected to have proton radiation therapy at University of Florida Proton Therapy Institute (UFPTI).

You may not qualify if…

• Current use of Flomax, Hytrin, Cardura, Uroxatral, or Rapaflo.
• History of vasectomy.
• Current use of Lupron, Zoladex, Trelstar, Casodex, Eulexin.
• Current use of Avodart or Proscar.

Where it is running

• University of Florida Proton Therapy Institute — Jacksonville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.